At the 2014 annual meeting of the American Society for Radiation Oncology (ASTRO), Sept. 14-17 at San Francisco’s Moscone Center, Siemens Healthcare demonstrated how it innovates to advance the practice of radiation therapy (RT) for the benefit of patients by providing systems and solutions that enable optimal imaging, which can support radiation therapy (RT) treatment and follow-up.

Cianna Medical Inc. announced five-year results for the first 200 hundred patients treated with the SAVI breast brachytherapy applicator, including excellent local control, low rates of toxicities and excellent cosmetic results.

September 16, 2014 — Advanced Accelerator Applications (AAA), an international specialist in molecular nuclear medicine, announced this week it has entered into an agreement with GE Healthcare in Italy to acquire its Italian FDG-PET imaging agent business (fluorodeoxyglucose positron emission tomography). This acquisition includes the license to market GE Healthcare’s SteriPET (FDG) imaging agent in Italy.

September 15, 2014 — A comparison of five-year sexual function outcomes, as reported by patients treated with external beam radiation therapy (EBRT) versus combination EBRT plus brachytherapy, indicates the utilization of vessel-sparing radiation therapy makes cure possible without compromising long-term sexual function, according to research presented today at ASTRO 2014.

September 15, 2014 — The American Association of Neurological Surgeons (AANS) and the American Society for Radiation Oncology (ASTRO) announced they are partnering to launch and support a national registry for stereotactic radiosurgery (SRS) treatments.

High-risk prostate cancer patients who receive radiation therapy and an 18-month course of androgen deprivation therapy recover a normal testosterone level in a shorter amount of time compared to those who receive a 36-month course of ADT, thus resulting in a better quality of life and without detriment to long-term outcomes, according to research presented at ASTRO 2014.